ABBV-155

ABBV-155 is a targeted ADC being investigated for the treatment of advanced hematologic malignancies and solid tumors.

Type of Molecule

Biologic

Target

n/a

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Hematologic Malignancies and Solid Tumors n/a
Phase 1